Sunshine Biopharma Signed Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound
Sunshine Biopharma Inc. (NASDAQ: SBFM) today announced the signing of a research agreement with Sir Mortimer B. Davis Jewish General Hospital, a McGill University Health Center hospital located in Montreal, Quebec, Canada.